SCHEMBL7880892

SCHEMBL7880892

CN(C(=N)N)C(=O)c1cc2cccc(OCc3ccc(CN)s3)c2[nH]1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 1/20 0.35
MAPT P10636 4/20 0.34
TP53 P04637 3/20 0.34
HRH4 Q9H3N8 2/20 0.33
IDO1 P14902 1/20 0.33
LOX P28300 1/20 0.33
DRD2 P14416 1/20 0.32
DRD3 P35462 1/20 0.32
FFAR1 O14842 1/20 0.32
AR P10275 2/20 0.32
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
ITGB3 P05106 1/20 0.30
ITGA2B P08514 1/20 0.30
LMNA P02545 1/20 0.30
KDM4E B2RXH2 1/20 0.30
MRGPRX4 Q96LA9 1/20 0.30
CFD P00746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7879978 0.91 FLT3 (0.35) FLT3MAPTTP53HRH4IDO1
SCHEMBL7880162 0.86 HRH4 (0.33) FLT3MAPTTP53HRH4IDO1
SCHEMBL7877636 0.86 CFD (0.43) FLT3MAPTTP53HRH4IDO1
SCHEMBL7873718 0.86 CFD (0.38) FLT3MAPTTP53HRH4IDO1
SCHEMBL7873278 0.85 MEN1 (0.39) FLT3MAPTTP53HRH4IDO1
SCHEMBL7884782 0.84 MEN1 (0.40) FLT3MAPTTP53HRH4IDO1
SCHEMBL7881260 0.84 MRGPRX4 (0.37) KDM4EMRGPRX4
Hydrochloric Acid SCHEMBL7877859 0.82 SRD5A2 (0.42) MAPTTP53IDO1LMNAMRGPRX4
SCHEMBL7880985 0.82 MGMT (0.42) FLT3MAPTTP53HRH4IDO1
SCHEMBL7880743 0.81 MRGPRX4 (0.32) MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed